KRAS-driven pancreatic cancer cells rely mainly on glutamine for their ability to survive in low glucose and amino acid environments, and are unable to survive glutamine deprivation even in the presence of other nutrients [100,101,102]. This evidence concerns the gene KRAS and pancreatic neoplasm.